Survey of human pharmaceuticals in drinking water in the Czech Republic

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11120%2F13%3A43907210" target="_blank" >RIV/00216208:11120/13:43907210 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/75010330:_____/13:00010069

Výsledek na webu

<a href="http://dx.doi.org/10.2166/wh.2013.056" target="_blank" >http://dx.doi.org/10.2166/wh.2013.056</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.2166/wh.2013.056" target="_blank" >10.2166/wh.2013.056</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Survey of human pharmaceuticals in drinking water in the Czech Republic

Popis výsledku v původním jazyce

The first large-scale assessment of pharmaceuticals in drinking water in the Czech Republic (CR) focused on the detection of five substances. Samples were collected from public water systems supplying 5.3 million people, 50.5% of the Czech population. Inthe initial survey of tap water from 92 major supply zones using mostly surface water, no pharmaceutical exceeded the limit of quantification (LOQ 1/4 0.5 ng/L). In a second survey, samples were collected from the outlet of 23 water treatment plants (WTPs) considered of high risk because they use surface waters influenced by wastewater. Ibuprofen was the most frequently found pharmaceutical (19 samples), followed by carbamazepine (12), naproxen (8), and diclofenac (3); concentrations ranged from 0.5 to20.7 ng/L, with medians below 6 ng/L. Concentrations of 17alfa-ethinylestradiol were below the LOQ. A follow-up survey included tap and outlet samples from eight of the 23 WTPs with the highest concentrations. Pharmaceuticals were quanti

Název v anglickém jazyce

Survey of human pharmaceuticals in drinking water in the Czech Republic

Popis výsledku anglicky

The first large-scale assessment of pharmaceuticals in drinking water in the Czech Republic (CR) focused on the detection of five substances. Samples were collected from public water systems supplying 5.3 million people, 50.5% of the Czech population. Inthe initial survey of tap water from 92 major supply zones using mostly surface water, no pharmaceutical exceeded the limit of quantification (LOQ 1/4 0.5 ng/L). In a second survey, samples were collected from the outlet of 23 water treatment plants (WTPs) considered of high risk because they use surface waters influenced by wastewater. Ibuprofen was the most frequently found pharmaceutical (19 samples), followed by carbamazepine (12), naproxen (8), and diclofenac (3); concentrations ranged from 0.5 to20.7 ng/L, with medians below 6 ng/L. Concentrations of 17alfa-ethinylestradiol were below the LOQ. A follow-up survey included tap and outlet samples from eight of the 23 WTPs with the highest concentrations. Pharmaceuticals were quanti

Druh

J_x - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)

CEP obor

DJ - Znečištění a kontrola vody

OECD FORD obor

—

Projekt

<a href="/cs/project/GA203%2F09%2F1583" target="_blank" >GA203/09/1583: Výskyt a zdravotní rizika zbytků humánních léčiv v pitných vodách</a><br>

Návaznosti

V - Vyzkumna aktivita podporovana z jinych verejnych zdroju

Rok uplatnění

2013

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Journal of Water and Health

ISSN

1477-8920

e-ISSN

—

Svazek periodika

11

Číslo periodika v rámci svazku

1

Stát vydavatele periodika

GB - Spojené království Velké Británie a Severního Irska

Počet stran výsledku

14

Strana od-do

84-97

Kód UT WoS článku

000319500300009

EID výsledku v databázi Scopus

—